Cite

    Manuel Kussmann et al.. “Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis.” Emerging microbes & infections, vol. 7, no. 1, 2018, pp. 1–10. http://access.bl.uk/ark:/81055/vdc_100099698592.0x00016b